Health3 weeks ago
Novo Nordisk Files Application for Innovative Haemophilia Treatment
Novo Nordisk has officially submitted a biologic marketing application for its innovative treatment, Mim8 (denecimig), to the United States Food and Drug Administration (FDA). This application...